Description

Monalisa Hard with Lidocaine

Monalisa Hard is a professional injectable dermal filler formulated with cross-linked hyaluronic acid and lidocaine. Its firmer gel and larger particle profile are designed for facial treatments requiring greater support than the softer formulations within the Monalisa collection.

Each prefilled syringe contains 1ml of transparent hyaluronic acid gel with 24mg/ml of cross-linked hyaluronic acid and 0.3% lidocaine. The incorporated lidocaine is intended to help improve patient comfort during administration.

Monalisa Hard is manufactured in South Korea by Genoss Co., Ltd. It must only be administered by an appropriately qualified, trained and insured healthcare or aesthetic professional.

What Is Monalisa Hard Used For?

Monalisa Hard is designed for professional correction and volume restoration in suitable facial areas. Manufacturer information identifies its recommended placement profile as the middle-to-deep layer of the subcutaneous tissue.

Published product information associates Monalisa Hard with suitable treatments involving forehead volume, nasolabial folds, the chin and the facial oval. These indications do not mean that the product is appropriate for every patient or every area. The practitioner must assess the patient’s facial anatomy, tissue quality, medical history and desired outcome before selecting a product.

The treatment area, placement depth, quantity and administration technique must be determined by the treating professional in accordance with the current instructions for use and applicable clinical standards.

Monalisa Hard Product Specifications

• Product: Monalisa Hard with Lidocaine
• Product type: Injectable hyaluronic acid dermal filler
• Syringe volume: 1ml
• Hyaluronic acid concentration: 24mg/ml
• Lidocaine concentration: 0.3%
• Particle size: Approximately 600 micrometres
• Recommended placement: Middle-to-deep layer of subcutaneous tissue
• Listed needle sizes: 25G and 27G thin-wall needles
• Manufacturer: Genoss Co., Ltd.
• Country of manufacture: South Korea
• Storage: 2°C to 25°C
• Use: Qualified professional use only

Needle sizes, accessories and packaging configurations may differ by market. Always inspect the exact box supplied and follow its current instructions rather than relying solely on an online description.

Key Features of Monalisa Hard

• Contains 24mg/ml of cross-linked hyaluronic acid
• Includes 0.3% lidocaine for improved treatment comfort
• Approximately 600-micrometre particle profile
• Firmer formulation intended for greater tissue support
• Designed for suitable middle-to-deep professional applications
• Supplied in a sterile, ready-to-use 1ml syringe
• Produced using Monalisa Hy-BRID technology
• Ergonomically designed syringe for controlled professional handling

Cross-Linked Hyaluronic Acid

Hyaluronic acid is naturally present in the human body and contributes to tissue hydration and structure. In a dermal filler, cross-linking creates a gel that can provide temporary physical support and volume when placed correctly within suitable tissue.

Monalisa Hard is manufactured using Genoss Hy-BRID technology. According to the manufacturer, this technology produces dense and uniform particles intended to offer balanced viscoelastic characteristics and volume retention.

The product is biodegradable and is not a permanent implant. How long a correction remains visible can vary according to the treatment area, product quantity, placement, patient metabolism, lifestyle and other individual factors. A particular treatment duration or aesthetic outcome cannot be guaranteed.

Monalisa Hard Compared with Other Monalisa Fillers

The Monalisa Lidocaine collection contains several formulations with different particle sizes and recommended placement profiles:

• Monalisa Soft: Approximately 200-micrometre particles for superficial placement
• Monalisa Mild: Approximately 400-micrometre particles for superficial or intermediate placement
• Monalisa Hard: Approximately 600-micrometre particles for middle-to-deep placement
• Monalisa Ultra: Approximately 900-micrometre particles for deep-to-very-deep placement

Monalisa Hard offers greater support than Soft or Mild while remaining less robust than the Ultra formulation. Practitioners should select a filler according to the required tissue support, intended placement level and individual treatment plan—not simply according to the depth of a visible line.

Professional Consultation and Assessment

A thorough consultation must be completed before using Monalisa Hard. The practitioner should review the patient’s medical history, allergies, medication, previous aesthetic procedures, skin condition and treatment expectations.

The patient should receive a clear explanation of the proposed treatment, its limitations, possible adverse effects, aftercare and alternative options. Informed consent must be obtained before administration. The product name, batch number, expiry date and traceability information should be recorded in the patient’s treatment notes.

Important Safety Information

Monalisa Hard must never be injected into a blood vessel. Accidental intravascular administration of any dermal filler can cause serious complications, including vascular occlusion, tissue ischaemia, necrosis, visual impairment, blindness or stroke.

Administration requires detailed knowledge of facial anatomy, appropriate aseptic technique and the ability to recognise and manage complications without delay. Qualified practitioners should have suitable emergency procedures, equipment and referral arrangements available.

Do not administer Monalisa Hard to a patient with known hypersensitivity to hyaluronic acid, lidocaine, amide-type local anaesthetics or another product component. Do not treat areas affected by active infection, inflammation, irritation, broken skin, untreated skin disease or an active cold-sore outbreak.

Pregnancy, breastfeeding, bleeding disorders, immune conditions, anticoagulant medication, severe allergies, susceptibility to problematic scarring and recent treatments in the same area require careful professional consideration. Consult the complete manufacturer’s instructions for all contraindications and precautions.

Possible Treatment Reactions

Temporary injection-site reactions can include redness, swelling, tenderness, bruising, itching, firmness, discomfort or discolouration. Other less common complications can be more serious and may require urgent treatment.

Patients should receive written aftercare instructions and understand how to contact their practitioner. Unexpected or increasing pain, blanching, unusual skin colour, visual disturbance or neurological symptoms require immediate professional assessment.

Storage, Inspection and Handling

Store Monalisa Hard between 2°C and 25°C unless the exact carton supplied states otherwise. Do not freeze the product or expose it to excessive heat.

Before use, inspect the carton, sterile barrier, syringe, gel, expiry date and batch information. Do not use the product if its packaging is damaged, its expiry date has passed or the gel appears abnormal.

The syringe and supplied needles are intended for single use only. Do not reuse or resterilise them. Dispose of the syringe, needles and remaining product as appropriate clinical and sharps waste.

Order Monalisa Hard

Monalisa Hard with Lidocaine is available from The Clinic Vault for eligible professional purchasers. Customers must ensure that they hold the qualifications, training, insurance and legal authority required to purchase and administer injectable aesthetic products.

Explore our professional aesthetic product collection or review the Genoss instructions-for-use library for available manufacturer documentation.

Professional-use notice: This page provides general product information. It does not replace the instructions supplied with the product, accredited clinical training, local regulations, professional judgement or an individual patient assessment.